Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07046936 · ClinicalTrials.gov registry record
Role of Mitochondrial Bioenergetics in Resilience for Gynecologic Cancer
A clinical trial of Gynecologycal Cancer, sponsored by Wake Forest University Health Sciences.
- Recruiting
- Registry status
- 30
- Enrollment target
- 2
- Study locations
NCT07046936: Recruiting study of Gynecologycal Cancer, sponsored by Wake Forest University Health Sciences.
NCT07046936 is a study of Gynecologycal Cancer that is actively recruiting participants, run by Wake Forest University Health Sciences. The registered enrollment target is 30 participants. The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07046936, a study of Gynecologycal Cancer, is actively recruiting participants, sponsored by Wake Forest University Health Sciences.
- RECRUITING
- Registry status
- 30 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this research study is to see if patients with endometrial and ovarian cancer are willing to complete physical and cognitive assessments before treatment and again after treatment has ended.
Primary Outcome
Proportion of approached patients who signed consent out of the total number of patients who were approached
Conditions Studied
Interventions
- OTHER blood draw
- DIAGNOSTIC_TEST muscle sample
Study Locations (2)
North Carolina
- Atrium Health Levine Cancer - Charlotte
- Atrium Health Wake Forest Baptist Comprehensive Cancer Center - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2026-06 |
| Est. Completion | 2027-04 |
What NCT07046936 shows while recruiting
NCT07046936 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.
The record links to 1 condition, with Gynecologycal Cancer appearing as the primary indexed condition, and to 2 interventions - of which blood draw is the first listed.
NCT07046936 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT07046936 about?
NCT07046936 is a clinical study titled "Role of Mitochondrial Bioenergetics in Resilience for Gynecologic Cancer". The purpose of this research study is to see if patients with endometrial and ovarian cancer are willing to complete physical and cognitive assessments before treatment and again after treatment has ended.
What is the current status of trial NCT07046936?
This trial is currently recruiting. The enrollment target is 30 participants. The study started on 2026-06. Estimated completion is 2027-04.
What conditions does trial NCT07046936 study?
This clinical trial studies the following conditions: Gynecologycal Cancer.
What interventions are being tested in trial NCT07046936?
The interventions under investigation include: blood draw (OTHER), muscle sample (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07046936?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07046936 being conducted?
This trial has 2 study locations across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia